Defining the optimal dose of aspirin and clopidogrel in acute coronary syndromes

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.1, 2011-01, pp. : 149-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel: a CURE in acute coronary syndromes?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 351-353

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Acute Coronary Syndromes: Medical Economics with an Emphasis on Clopidogrel

By Bramkamp Matthias Dedes Konstantin Szucs Thomas

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 4, 2005-08 ,pp. : 291-299

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Clopidogrel in Revascularized and Nonrevascularized Patients with Acute Coronary Syndromes

By Collins J. Stewart Gurm Hitinder S.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 3, 2007-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1761-1764

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel: Potential In the Prevention of Cardiovascular Events in Patients with Acute Coronary Syndromes

By Easthope S.E. Jarvis B.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 467-474

Adis International

Access to resources Recommend Favorite